Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Revital Faro

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Obstetrics and Gynecology|February 21, 2012
Twins--twice more trouble?Joaquin Santolaya, Revital Faro
Reproductive Sciences (Thousand Oaks, Calif.)|July 10, 2015
Mode of Delivery in Stillbirth, 1995-2004Valeria Di Stefano, Joaquín Santolaya-Forgas, Revital Faro, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|June 20, 2012
Paternal age and risk for cesarean deliveryRevital Faro, Joaquin Santolaya-Forgas, Joseph C Canterino, et al.
Journal of Assisted Reproduction and Genetics|November 7, 2013
Screening for Down syndrome in dichorionic twin pregnancies conceived by in vitro fertilization (IVF): a clinical pilot study to confirm the laboratory methodsLissa Francois, Lindsay Kugler, Jacobo L Santolaya, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|August 12, 2020
Fetal Exosomal Platelet-activating Factor Triggers Functional Progesterone Withdrawal in Human PlacentaKristy T Palomares, Nataliya Parobchak, Mayra Cruz Ithier, et al.
American Journal of Obstetrics and Gynecology|March 25, 2023
Obstetrical, perinatal, and genetic outcomes associated with nonreportable prenatal cell-free DNA screening resultsMary E Norton, Cora MacPherson, Zachary Demko, et al.
Prenatal Diagnosis|December 9, 2023
Impact of high-risk prenatal screening results for 22q11.2 deletion syndrome on obstetric and neonatal management: Secondary analysis from the SMART studyKimberly Martin, Mary E Norton, Cora MacPherson, et al.
American Journal of Obstetrics and Gynecology|March 3, 2024
The role of cell-free DNA biomarkers and patient data in the early prediction of preeclampsia: an artificial intelligence modelAsma Khalil, Giovanni Bellesia, Mary E Norton, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 8, 2023
Performance of prenatal cfDNA screening for sex chromosomesKimberly Martin, Pe'er Dar, Cora MacPherson, et al.
American Journal of Obstetrics and Gynecology|January 16, 2022
Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndromePe'er Dar, Bo Jacobsson, Rebecca Clifton, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Obstetrics and Gynecology|February 21, 2012
Twins--twice more trouble?Joaquin Santolaya, Revital Faro
Reproductive Sciences (Thousand Oaks, Calif.)|July 10, 2015
Mode of Delivery in Stillbirth, 1995-2004Valeria Di Stefano, Joaquín Santolaya-Forgas, Revital Faro, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|June 20, 2012
Paternal age and risk for cesarean deliveryRevital Faro, Joaquin Santolaya-Forgas, Joseph C Canterino, et al.
Journal of Assisted Reproduction and Genetics|November 7, 2013
Screening for Down syndrome in dichorionic twin pregnancies conceived by in vitro fertilization (IVF): a clinical pilot study to confirm the laboratory methodsLissa Francois, Lindsay Kugler, Jacobo L Santolaya, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|August 12, 2020
Fetal Exosomal Platelet-activating Factor Triggers Functional Progesterone Withdrawal in Human PlacentaKristy T Palomares, Nataliya Parobchak, Mayra Cruz Ithier, et al.
American Journal of Obstetrics and Gynecology|March 25, 2023
Obstetrical, perinatal, and genetic outcomes associated with nonreportable prenatal cell-free DNA screening resultsMary E Norton, Cora MacPherson, Zachary Demko, et al.
Prenatal Diagnosis|December 9, 2023
Impact of high-risk prenatal screening results for 22q11.2 deletion syndrome on obstetric and neonatal management: Secondary analysis from the SMART studyKimberly Martin, Mary E Norton, Cora MacPherson, et al.
American Journal of Obstetrics and Gynecology|March 3, 2024
The role of cell-free DNA biomarkers and patient data in the early prediction of preeclampsia: an artificial intelligence modelAsma Khalil, Giovanni Bellesia, Mary E Norton, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 8, 2023
Performance of prenatal cfDNA screening for sex chromosomesKimberly Martin, Pe'er Dar, Cora MacPherson, et al.
American Journal of Obstetrics and Gynecology|January 16, 2022
Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndromePe'er Dar, Bo Jacobsson, Rebecca Clifton, et al.
Pageof 2